Your browser doesn't support javascript.
loading
Perturbed actin cap as a new personalized biomarker in primary fibroblasts of Huntington's disease patients.
Gharaba, Saja; Paz, Omri; Feld, Lea; Abashidze, Anastasia; Weinrab, Maydan; Muchtar, Noam; Baransi, Adam; Shalem, Aviv; Sprecher, Uri; Wolf, Lior; Wolfenson, Haguy; Weil, Miguel.
Afiliação
  • Gharaba S; Laboratory for Personalized Medicine and Neurodegenerative Diseases, The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty for Life Sciences, Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel.
  • Paz O; Laboratory for Personalized Medicine and Neurodegenerative Diseases, The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty for Life Sciences, Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel.
  • Feld L; Department of Genetics and Developmental Biology, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.
  • Abashidze A; The Blavatnik Center for Drug Discovery, Tel Aviv University, Tel Aviv, Israel.
  • Weinrab M; Laboratory for Personalized Medicine and Neurodegenerative Diseases, The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty for Life Sciences, Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel.
  • Muchtar N; Laboratory for Personalized Medicine and Neurodegenerative Diseases, The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty for Life Sciences, Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel.
  • Baransi A; Laboratory for Personalized Medicine and Neurodegenerative Diseases, The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty for Life Sciences, Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel.
  • Shalem A; Laboratory for Personalized Medicine and Neurodegenerative Diseases, The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty for Life Sciences, Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel.
  • Sprecher U; The Blavatnik School of Computer Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Wolf L; School of Electrical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
  • Wolfenson H; Laboratory for Personalized Medicine and Neurodegenerative Diseases, The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty for Life Sciences, Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel.
  • Weil M; The Blavatnik School of Computer Sciences, Tel Aviv University, Tel Aviv, Israel.
Front Cell Dev Biol ; 11: 1013721, 2023.
Article em En | MEDLINE | ID: mdl-36743412
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel